Sonal uses non-invasive technology to reshape brainwaves and effectively improve brain health for general well-being. Credit: Wave Neuroscience/Business Wire.

Braincare Company Wave Neuroscience has launched its new at-home general wellness device, Sonal, for personalised neuromodulation.

The device uses non-invasive technology to help reshape brainwaves and effectively improve brain health for general wellbeing.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

By providing a customised plan tailored to fit an individual’s needs, Sonal helps to improve brain health and mental wellness.

Wave Neuroscience CEO Fred Walke said: “By introducing the first at-home device, we are able to remove one roadblock some face when deciding whether to seek care.”

To create a personalised Braincare plan, an individual’s brainwaves will be recorded for ten minutes and then reviewed by the Department of Data Science at Wave using neurocomputational analytics.

The individualised plan will be uploaded to the mobile Sonal app once created.

Sonal sessions take 30 minutes, and users may experience increased focus, improved sleep quality and elevated mood.

Users may also notice a significant improvement in self-control by using the device for consecutive weeks.

It also improves Heart Rate Variability (HRV), which is connected to resilience to stress and improved deep sleep.

Wave Neuroscience president and chief medical officer Erik Won said: “One of our core values is democratising brain health and the development of Sonal is a tremendous step in the right direction.

“Neuronal function can gradually degrade over time due to numerous factors and stressors, such as chronic stress, sleep disruption, loss of a loved one, traumatic events, substance use and more.

“The Sonal has demonstrated promising data in double-blind randomised clinical trials at elite academic institutions.”

Sonal is a mobile wearable device that can be used for personalised Braincare anywhere.